Skip to content

Assessment of the implementation of an educational action focused on patients with poor anticoagulation control in two teaching hospitals

Assessment of of the implementation of an Educational Intervention focused on patients with poor anticoagulation control using vitamin K antagonist in two teaching hospitals

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9cy6py
Enrollment
Unknown
Registered
2019-03-28
Start date
2018-12-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrilation

Interventions

Experimental group: 85 individuals followed at least six months at Hospital das Clínicas de Minas Gerais, therapeutic time range below sixty percent, age above or equal eighteen years, both sexes, va
Behavioural
I02.233.332

Sponsors

Universidade Federal de Minas Gerais
Lead Sponsor
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Collaborator

Eligibility

Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: Eighteen years of age or more, both sexes, follow up in the anticoagulation clinics for at least six months, valvular or non valvular atrial fibrilation as indication for warfarin use and time in therapeutic range below the percentage of sixty

Exclusion criteria

Exclusion criteria: Bedridden patients or limitation of locomotion that compromises the attendance to scheduled visits, blind or deaf, aphasia or other speech disorders that could hinder communication during study, dementia diagnosis reported in medical records, less than two international normalized ratio values in the study period

Design outcomes

Primary

MeasureTime frame
To assess the increase in the quality of oral anticoagulation, measured by Time in the Therapeutic Range (TTR) of a historical series of international normalized relation (RNI) tests, measured by the Rosendaal method. It is expected a 6 percent increase in TTR values after the intervention, when compared to the period prior to the offer. Thus, the TTR analysis will occur before intervention and at zero times (immediately after), three, six, nine and 12 months after the intervention.

Secondary

MeasureTime frame
Assess the knowledge about oral anticoagulation control. The Oral Anticoagulation Knowledge (OAK) test will be applied to assess knowledge on warfarin therapy. It has been recently validated to be used in the Brazilian population. The instrument consists of 20 questions with four possible answers and only one correct option. Each correct answer scores one point, leading to a total score ranging from 0 to 20 points. Higher scores (>75 percent) indicate better knowledge levels about warfarin therapy. hat knowledge takes time to change, this variable will be measured before and at zero times (immediately after), six, and 12 months after the intervention.;Assess the self-reported adherence to warfarin therapy.Self-reported adherence will be evaluated by reviewing patient records in the hospital computerized system. It has been deemed to be an adequate method comparable to other instruments applied to assess adherence. Non-adherence will be considered as missing warfarin doses or administration errors according to prescribed dosing regimen. We expect a decrease of 2 percent in the percentage of patients reporting an adhesion problem and who will receive the intervention. We will be measured six months before starting the intervention, immediately after intervention completion ) and at three, six, nine and twelve months after intervention.

Countries

Brazil

Contacts

Public ContactJosiane;Maria Costa;Parreiras Marins

Universidade Federal de Minas Gerais;Universidade Federal de Minas Gerais

josycostta2@yahoo.com.br;auxiliadorapmartins@hotmail.com+55-031984114560;+55-031984114560

Outcome results

None listed

Source: REBEC (via WHO ICTRP)